Chemoinformaics analysis of ETHYL ISOPROPYL ETHER
| Molecular Weight | 88.15 | nRot | 2 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 0 |
| Exact Molecular Weight | 88.0888 | nRing | 0 |
| Solubility: LogS | -0.546 | nHRing | 0 |
| Solubility: LogP | 1.261 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 17.1535 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.496 |
| Synth | 2.181 |
| Natural Product Likeliness | -0.708 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.05 |
| MDCK | 0.0000372 |
| BBB | 0.962 |
| PPB | 0.202712 |
| VDSS | 1.16 |
| FU | 0.69925 |
| CYP1A2-inh | 0.55 |
| CYP1A2-sub | 0.549 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.885 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.158 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.379 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.321 |
| CL | 8.651 |
| T12 | 0.735 |
| hERG | 0.021 |
| Ames | 0.028 |
| ROA | 0.018 |
| SkinSen | 0.088 |
| Carcinogencity | 0.17 |
| EI | 0.944 |
| Respiratory | 0.023 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.944833 |